Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperoxaluric calcium nephrolithiasis.

John R Asplin1

  • 1University of Chicago and Litholink Corporation, 2250 W. Campbell Park Drive, Chicago, IL 60612, USA. jasplin@litholink.com

Endocrinology and Metabolism Clinics of North America
|December 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Reported Human Cases of Urolithin A Renal Calculi.

Kidney international reports·2026
Same author

Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention.

The Journal of urology·2026
Same author

Comparison of Thiazide Versus Alkali for Kidney Stone Recurrence Among Individuals With Hypocitraturia and High Urine pH.

Kidney medicine·2025
Same author

Correction to: The Effect of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists on 24-Hour Urine Parameters: A Retrospective Cohort Study.

Kidney360·2025
Same author

Acute Changes in 24-Hour Lithogenic Urine Measures Intra- and Post-Partum.

Urology·2025
Same author

Effect of Chlorthalidone and Hydrochlorothiazide on 12-Hour vs 24-Hour Urinary Calcium Excretion.

The Journal of urology·2025
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Hyperoxaluria causes kidney stones. While primary hyperoxaluria treatments improved, mild hyperoxaluria options are limited due to poor understanding of diet

Area of Science:

  • Nephrology
  • Urology
  • Nutritional Science

Background:

  • Hyperoxaluria increases calcium oxalate supersaturation and kidney stone formation.
  • Excess oxalate originates from endogenous overproduction (primary hyperoxaluria) or diet.
  • Recent advancements in primary hyperoxaluria diagnosis and treatment contrast with limited options for mild hyperoxaluria.

Purpose of the Study:

  • To address the knowledge gaps in treating mild hyperoxaluria.
  • To explore novel therapeutic strategies for hyperoxaluric calcium nephrolithiasis.

Main Methods:

  • Review of recent studies on oxalate metabolism.
  • Investigation of dietary oxalate content and precursors.
  • Analysis of intestinal oxalate absorption factors.

Related Experiment Videos

  • Exploration of oxalate-degrading bacteria.

    • Main Results:

    • Inadequate knowledge of food oxalate content, oxalate precursors, and intestinal handling hinders rational therapy development.
    • Emerging research on oxalate-degrading bacteria shows promise.
    • Renewed interest in dietary calcium's role in oxalate absorption may offer new strategies.

    Conclusions:

    • Better understanding of dietary oxalate and intestinal handling is crucial for developing effective therapies.
    • Oxalate-degrading bacteria and dietary calcium modulation represent potential future treatments for hyperoxaluric calcium nephrolithiasis.